Industry Supported Sessions Programs

Industry Supported Sessions Programs

FRIDAY, MARCH 29, 2019

INDUSTRY SESSION 11: 

FROM MICE TO MEN: INCREASING PREDICTIVE VALUE IN CNS DRUG DEVELOPMENT

SYMPOSIUM IS ORGANISED AND SUPPORTED BY PGI/NSC

Friday, March 29| 17:15 - 19:15 | Auditorium VI+VII

Chairs:  Manfred Windisch (AUSTRIA) and Emer Leahy (USA)         


17:15–17:35    NEXT-GENERATION MOUSE MODELS OF ALZHEIMER'S DISEASE

Gregory Carter (USA)

 

17:35–17:55    HIGH CONTENT PHENOTYPING AND MACHINE LEARNING APPROACHES TO AD DRUG DISCOVERY

Emer Leahy (USA)


17:55–18:15    INSIGHTS INTO ALTERED CNS FUNCTION BY EEG BIOMARKERS: APPLICATION TO AD DRUG DISCOVERY
Steve Leiser (USA)

 

18:15–18:35    LINKING EXPERIMENTAL MODELS OF AD TO PRECLINICAL AND CLINICAL DRUG                        DEVELOPMENT PROGRAMS

                        Eliezer Masliah (USA)

 

18:35–18:55    ADVANCED MEDICAL IMAGE HANDLING AND ANALYSIS IN CNS CLINICAL TRIALS
Matt Rowe (UK)

 

18:55-19:15     DRUG DEVELOPMENT IN AD - CHALLENGES IN CLINIC AND BEHAVIORAL TESTING
Jakub Hort (CZECH REPUBLIC)